172 related articles for article (PubMed ID: 20501911)
1. Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo.
Donato MT; Hallifax D; Picazo L; Castell JV; Houston JB; Gomez-Lechón MJ; Lahoz A
Drug Metab Dispos; 2010 Sep; 38(9):1449-55. PubMed ID: 20501911
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance.
Foster JA; Houston JB; Hallifax D
Xenobiotica; 2011 Feb; 41(2):124-36. PubMed ID: 21058916
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.
Brown HS; Griffin M; Houston JB
Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance.
Griffin SJ; Houston JB
Drug Metab Dispos; 2004 May; 32(5):552-8. PubMed ID: 15100178
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
[TBL] [Abstract][Full Text] [Related]
7. Prediction of in vitro intrinsic clearance from hepatocytes: comparison of suspensions and monolayer cultures.
Griffin SJ; Houston JB
Drug Metab Dispos; 2005 Jan; 33(1):115-20. PubMed ID: 15608354
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intrinsic metabolic clearance in fresh and cryopreserved human hepatocytes.
Floby E; Johansson J; Hoogstraate J; Hewitt NJ; Hill J; Sohlenius-Sternbeck AK
Xenobiotica; 2009 Sep; 39(9):656-62. PubMed ID: 19622023
[TBL] [Abstract][Full Text] [Related]
9. Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepines.
Hallifax D; Rawden HC; Hakooz N; Houston JB
Drug Metab Dispos; 2005 Dec; 33(12):1852-8. PubMed ID: 16174807
[TBL] [Abstract][Full Text] [Related]
10. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
[TBL] [Abstract][Full Text] [Related]
11. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
Gorski JC; Huang SM; Pinto A; Hamman MA; Hilligoss JK; Zaheer NA; Desai M; Miller M; Hall SD
Clin Pharmacol Ther; 2004 Jan; 75(1):89-100. PubMed ID: 14749695
[TBL] [Abstract][Full Text] [Related]
12. Are there differences in the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9? A systematic investigation into inter-system extrapolation factors.
Crewe HK; Barter ZE; Yeo KR; Rostami-Hodjegan A
Biopharm Drug Dispos; 2011 Sep; 32(6):303-18. PubMed ID: 21725985
[TBL] [Abstract][Full Text] [Related]
13. Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations.
Jones HM; Houston JB
Drug Metab Dispos; 2004 Sep; 32(9):973-82. PubMed ID: 15319339
[TBL] [Abstract][Full Text] [Related]
14. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Masica AL; Mayo G; Wilkinson GR
Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
[TBL] [Abstract][Full Text] [Related]
15. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
Riley RJ; McGinnity DF; Austin RP
Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes.
Lu C; Li P; Gallegos R; Uttamsingh V; Xia CQ; Miwa GT; Balani SK; Gan LS
Drug Metab Dispos; 2006 Sep; 34(9):1600-5. PubMed ID: 16790553
[TBL] [Abstract][Full Text] [Related]
17. Rifampin induces the in vitro oxidative metabolism, but not the in vivo clearance of diclofenac in rhesus monkeys.
Prueksaritanont T; Li C; Tang C; Kuo Y; Strong-Basalyga K; Carr B
Drug Metab Dispos; 2006 Nov; 34(11):1806-10. PubMed ID: 16928785
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
19. Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes.
Feidt DM; Klein K; Hofmann U; Riedmaier S; Knobeloch D; Thasler WE; Weiss TS; Schwab M; Zanger UM
Drug Metab Dispos; 2010 Sep; 38(9):1589-97. PubMed ID: 20551241
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. II. In vitro-in vivo correlation with ketoconazole.
Lu C; Hatsis P; Berg C; Lee FW; Balani SK
Drug Metab Dispos; 2008 Jul; 36(7):1255-60. PubMed ID: 18381489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
